<DOC>
	<DOC>NCT02677454</DOC>
	<brief_summary>To evaluate the accuracy of the Flash Glucose Monitoring system (FGM), Abbot FreeStyle Libre, used today in clinical practice in Sweden in estimating plasma glucose levels. Data will be collected in ambulatory patients with type 1 diabetes to determine safety, accuracy, and reliability.</brief_summary>
	<brief_title>Evaluation of a Flash Glucose Monitoring System in Ambulatory Patients With Type 1 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 1</mesh_term>
	<criteria>1. Type 1 diabetes 2. Adult patients, age 18 or older and &lt; 75 years 3. Written informed consent 1. Pregnancy 2. Patients with severe cognitive dysfunction or other disease which makes FGM use difficult 3. History of allergic reaction to any of the FGMs materials or adhesives in Contact with the skin. 4. History of allergic reaction to chlorhexidine or alcohol antiseptic solution. 5. Continous Glucose Monitor (CGM) or FGM usage in the last month 6. Abnormal skin at the anticipated glucose sensor attachment sites(excessive hair, burn, inflammation, infection, rash, and/or tattoo)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Blood Glucose</keyword>
	<keyword>Blood Glucose Self-Monitoring</keyword>
</DOC>